Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Phase 2 study of CAStem Cell Injection for acute respiratory distress syndrome
CTR20221454Phase 2Active
- Sponsor
- Zehui Chenxing
- Start
- Jun 2022
- Modality
- Stem Cell Therapies → Cell Therapies
- Countries
- 1
01
Overview
A Phase 2 trial of CAStem cells in acute respiratory distress syndrome (ARDS), sponsored by Zehui Chenxing. Started Jun 2022; status: active.
02
Drugs
CAStem cells
03
Conditions
acute respiratory distress syndrome (ARDS)
Beyond the preview
Go deeper on CTR20221454.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on CTR20221454.